Get my own profile
Public access
View all6 articles
2 articles
available
not available
Based on funding mandates
Co-authors
- Rajender R. Aparasu, PhD, FAPhADepartment of Pharmaceutical Health Outcomes and Policy - University of Houston College of PharmacyVerified email at uh.edu
- Ryan CarnahanAssociate Professor of Epidemiology, the University of IowaVerified email at uiowa.edu
- Satabdi ChatterjeeBoehringer-IngelheimVerified email at boehringer-ingelheim.com
- Pravin S Kamble, PhDAssociate Director, Takeda PharmaceuticalsVerified email at takeda.com
- Maurice (Mark) Moffett, PhDAdvanta Government ServicesVerified email at AdvantaGovernmentServices.com
- Alain KoyamaCenters for Disease Control and PreventionVerified email at cdc.gov
- Marc FlemingChapman University School of Pharmacy (CUSP)Verified email at Chapman.edu
- Hemal MehtaAssociate Professor of Epidemiology, Bloomberg School of Public Health, Johns Hopkins UniversityVerified email at jhu.edu
- Xin WangUniversity of HoustonVerified email at uh.edu
- Mo YangUniversity of HoustonVerified email at uh.edu
- Saurabh NagarRTI - Health SolutionsVerified email at rti.org
- Shalak S. GunjalUniversity of WashingtonVerified email at uw.edu
- Pratik RaneDirector, CORE oncology, MerckVerified email at merck.com
- Luisa FranziniUniversity of MarylandVerified email at umd.edu